Prevention of lymphocyte cell death in sepsis improves survival in mice.
暂无分享,去创建一个
S. Korsmeyer | R. Hotchkiss | J. Cobb | Katherine C. Chang | P. Swanson | K. Tinsley | I. Karl | S. Korsmeyer | T. Buchman | K. Chang
[1] R. Hotchkiss,et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. , 1999, Critical care medicine.
[2] S. Korsmeyer,et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. , 1999, Journal of immunology.
[3] J. Lederer,et al. The effects of injury on the adaptive immune response. , 1999, Shock.
[4] J. Cleveland,et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis , 1999, Nature Medicine.
[5] G. Bernard. Research in sepsis and acute respiratory distress syndrome: are we changing course? , 1999, Critical Care Medicine.
[6] S. Nasraway. Sepsis research: we must change course. , 1999, Critical care medicine.
[7] P. Auberger,et al. A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] N. Thornberry,et al. Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.
[9] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[10] Z. Wang,et al. Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations. , 1998, Journal of immunology.
[11] S. Garg,et al. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. , 1998, Critical care medicine.
[12] Huiling He,et al. Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves Bc1-2 regulated caspase activation , 1998, Molecular and Cellular Endocrinology.
[13] M. Moskowitz,et al. Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] E. Deitch. ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED , 1998, Shock.
[15] R. Hotchkiss,et al. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. , 1997, Critical care medicine.
[16] John Calvin Reed. Double identity for proteins of the Bcl-2 family , 1997, Nature.
[17] K. Asadullah,et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment , 1997, Nature Medicine.
[18] Guido Kroemer,et al. The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.
[19] T. Kay,et al. Lymphocytopenia in a hospital population--what does it signify? , 1997, Australian and New Zealand journal of medicine.
[20] G. Evan,et al. 15 Methods for Detecting and Quantifying Apoptosis , 1997 .
[21] P. Henkart,et al. Different Interleukin-1β Converting Enzyme (ICE) Family Protease Requirements for the Apoptotic Death of T Lymphocytes Triggered by Diverse Stimuli , 1996, The Journal of experimental medicine.
[22] S. Nagata,et al. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death , 1996, The Journal of experimental medicine.
[23] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[24] I. Chaudry,et al. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. , 1996, Blood.
[25] P. Amiri,et al. Requirement of an ICE-Like Protease for Induction of Apoptosis and Ceramide Generation by REAPER , 1996, Science.
[26] Patrick R. Griffin,et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.
[27] I. Chaudry,et al. THE INDUCTION OF ACCELERATED THYMIC PROGRAMMED CELL DEATH DURING POLYMICROBIAL SEPSIS: CONTROL BY CORTICOSTEROIDS BUT NOT TUMOR NECROSIS FACTOR , 1995, Shock.
[28] Y. S. Lin,et al. Sepsis-induced apoptosis of the thymocytes in mice. , 1994, Journal of immunology.
[29] R. Stone. Search for sepsis drugs goes on despite past failures. , 1994, Science.
[30] J. L. Rodriguez,et al. Lymphocyte subset responses to trauma and sepsis. , 1993, The Journal of trauma.
[31] J. Palmer,et al. The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis. , 1993, The Journal of rheumatology.
[32] Suzanne Cory,et al. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.
[33] S. Korsmeyer,et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.
[34] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[35] C. Fathman,et al. Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2. , 1989, Journal of immunology.